Antimalarial drug chloroquine counteracts activation of indoleamine (2,3)-dioxygenase activity in human PBMC

FEBS Open Bio

Volumn 2, Issue , 2012, Pages 241-245

  Gostner, Johanna M ^a   Schröcksnadel, Sebastian ^a   Becker, Kathrin ^a   Jenny, Marcel ^a   Schennach, Harald ^b   Überall, Florian ^a   Fuchs, Dietmar ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Chloroquine; Indoleamine (2,3) dioxygenase (IDO); Neopterin; PBMC; Tryptophan

Indexed keywords

CHLOROQUINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 2 RECEPTOR ALPHA; KYNURENINE; LIPOPOLYSACCHARIDE; MITOGENIC AGENT; NEOPTERIN; TRYPTOPHAN;

AMINO ACID METABOLISM; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

EID: 84867298900     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2012.08.004     Document Type: Article

References (47)

1. Surrey A.R., Hammer H.F. Some 7-substituted 4-aminoquinoline derivatives. J. Am. Chem. Soc. 1946, 68:113-116.
2. Cooper R.G., Magwere T. Chloroquine: novel uses & manifestations. Indian J. Med. Res. 2008, 127:305-316.
3. Thorens B., Vassalli P. Chloroquine and ammonium chloride prevent terminal glycosylation of immunoglobulins in plasma cells without affecting secretion. Nature 1986, 321:618-620.
4. Gonzalez-Noriega A., Grubb J.H., Talkad V., Sly W.S. Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling. J. Cell Biol. 1980, 85:839-852.
5. Magwere T., Naik Y.S., Hasler J.A. Effects of chloroquine treatment on antioxidant enzymes in rat liver and kidney. Free Radic Biol Med. 1997, 22:321-327.
6. Toler S.M., Noe D., Sharma A. Selective enhancement of cellular oxidative stress by chloroquine: implications for the treatment of glioblastoma multiforme. Neurosurg. Focus 2006, 21:E10.
7. Krishna S., White N.J. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin. Pharmacokinet. 1996, 30:263-299.
8. Lin J.T., Juliano J.J., Wongsrichanalai C. Drug-resistant malaria: the era of ACT. Curr. Infect. Dis. Rep. 2010, 12:165-173.
9. Ballal A., Saeed A., Rouina P., Jelkmann W. Effects of chloroquine treatment on circulating erythropoietin and inflammatory cytokines in acute Plasmodium falciparum malaria. Ann. Hematol. 2009, 88:411-415.
10. Weber S.M., Levitz S.M. Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism. J. Immunol. 2000, 165:1534-1540.
11. van den Borne B.E., Dijkmans B.A., de Rooij H.H., le Cessie S., Verweij C.L. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. J. Rheumatol. 1997, 24:55-60.
12. Ben-Zvi I., Kivity S., Langevitz P., Shoenfeld Y. Hydroxychloroquine: from malaria to autoimmunity. Clin. Rev. Allergy Immunol. 2012, 42:145-153.
13. Wozniacka A., Lesiak A., Narbutt J., McCauliffe D.P., Sysa-Jedrzejowska A. Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients. Lupus 2006, 15:268-275.
14. Ornstein M.H., Sperber K. The antiinflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis. Arthritis Rheum. 1996, 39:157-161.
15. Fox R.I. Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin. Arthritis Rheum. 1993, 23:82-91.
16. Billiau A., Heremans H., Vermeire K., Matthys P. Immunomodulatory properties of interferon-gamma. An update. Ann. NY Acad. Sci. 1998, 856:22-32.
17. Saha B., Jyothi Prasanna S., Chandrasekar B., Nandi D. Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 2010, 50:1-14.
18. Smale S.T. Hierarchies of NF-κB target-gene regulation. Nat. Immunol. 2011, 12:689-694.
19. Murr C., Widner B., Wirleitner B., Fuchs D. Neopterin as a marker for immune system activation. Curr. Drug Metab. 2002, 3:175-187.
20. Weiss G., Fuchs D., Hausen A., Reibnegger G., Werner E.R., Werner-Felmayer G., Semenitz E., Dierich M.P, Wachter H. Neopterin modulates toxicity mediated by reactive oxygen and chloride species. FEBS Lett 1993, 321:89-92.
21. Razumovitch J.A., Semenkova G.N., Fuchs D., Cherenkevich S.N. Influence of neopterin on the generation of reactive oxygen species in human neutrophils. FEBS Lett 2003, 549:83-86.
22. Hoffmann G., Schobersberger W., Frede S., Pelzer L., Fandrey J., Wachter H., Fuchs D., Grote J. Neopterin activates transcription factor nuclear factor-kappa B in vascular smooth muscle cells. FEBS Lett 1996, 391:181-184.
23. Taylor M.W., Feng G.S. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 1991, 5:2516-2522.
24. Schröcksnadel K., Wirleitner B., Winkler C., Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin. Chim Acta 2006, 364:82-90.
25. Schroecksnadel K., Kaser S., Ledochowski M., Neurauter G., Mur E., Herold M., Fuchs D. Increased degradation of tryptophan in blood of patients with rheumatoid arthritis. J. Rheumatol. 2003, 30:1935-1939.
26. Schroecksnadel K., Winkler C., Duftner C., Wirleitner B., Schirmer M., Fuchs D. Tryptophan degradation increases with stage in patients with rheumatoid arthritis. Clin. Rheumatol. 2006, 25:334-337.
27. Reibnegger G., Boonpucknavig V., Fuchs D., Hausen A., Schmutzhard E., Wachter H. Urinary neopterin is elevated in patients with malaria. Trans. R. Soc. Trop. Med. Hyg. 1984, 78:545-546.
28. Reibnegger G., Fuchs D., Hausen A., Schmutzhard E., Werner E.R., Wachter H. The dependence of cell-mediated immune activation in malaria on age and endemicity. Trans. R. Soc. Trop. Med. Hyg. 1987, 81:729-733.
29. Brown A.E., Webster H.K., Teja-Isavadharm P., Keeratithakul D. Macrophage activation in falciparum malaria as measured by neopterin and interferon-gamma. Clin. Exp. Immunol. 1990, 82:97-101.
30. Kremsner P.G., Feldmeier H., Zotter G.M., Jansen-Rosseck R., Graninger W., Rocha R.M., Bienzle U. Immunological alterations in uncomplicated Plasmodium falciparum malaria. Relationship between parasitaemia and indicators of macrophage activation. Acta Trop. 1989, 46:351-359.
31. Tetsutani K., To H., Torii M., Hisaeda H., Himeno K. Malaria parasite induces tryptophan-related immune suppression in mice. Parasitology 2007, 134:923-930.
32. Jenny M., Klieber M., Zaknun D., Schroecksnadel S., Kurz K., Ledochowski M., Schennach H., Fuchs D. In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors. Inflamm. Res. 2011, 60:127-135.
33. Schroecksnadel S., Jenny M., Kurz K., Klein A., Ledochowski M., Uberall F., Fuchs D. LPS-induced NF-kappaB expression in THP-1 Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase. Biochem. Biophys. Res. Commun. 2010, 399:642-646.
34. Samsonov M.Y., Tilz G.P., Pisklakov V.P., Reibnegger G., Nassonov E.L., Nassonova V.A., Wachter H., Fuchs D. Serum-soluble receptors for tumor necrosis factor-alpha and interleukin-2, and neopterin in acute rheumatic fever. Clin. Immunol. Immunopathol. 1995, 74:31-34.
35. Widner B., Werner E.R., Schennach H., Wachter H., Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin. Chem. 1997, 43:2424-2426.
36. Goldring J.P., Nemaorani S. Antimalarial drugs modulate the expression of monocyte receptors. Int. J. Immunopharmacol. 1999, 21:599-607.
37. Cumming B.M., Watson G.M., Goldring J.P. Plasmodium falciparum: effect of antimalarial drugs, malaria pigment (β-haematin) and Plasmodium falciparum lysate on monocyte GTP-cyclohydrolase 1 gene expression. Exp. Parasitol. 2011, 129:312-317.
38. He Y., Xu Y., Zhang C., Gao X., Dykema K.J., Martin K.R., Ke J., Hudson E.A., Khoo S.K., Resau J.H., Alberts A.S., MacKeigan J.P., Furge K.A., Xu H.E. Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response. Sci. Signal. 2011, 4:ra44.
39. Schroecksnadel K., Winkler C., Wirleitner B., Schennach H., Fuchs D. Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro. Clin. Exp. Immunol. 2005, 140:41-45.
40. Schroecksnadel S., Sucher R., Kurz K., Fuchs D., Brandacher G. Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells. Transpl. Immunol. 2011, 25:119-123.
41. Cepika A.M., Bendelja K., Vergles J.M., Malenica B., Kapitanovic S., Gagro A. Monocyte response to LPS after exposure to corticosteroids and chloroquine with implications for systemic lupus erythematosus. Scand. J. Immunol. 2010, 72:434-443.
42. Park J., Kwon D., Choi C., Oh J.W., Benveniste E.N. Chloroquine induces activation of nuclear factor-kappaB and subsequent expression of pro-inflammatory cytokines by human astroglial cells. J. Neurochem. 2003, 84:1266-1274.
43. Eperon S., Jungi T.W. The use of human monocytoid lines as indicators of endotoxin. J. Immunol. Methods 1996, 194:121-129.
44. Rolain J.M., Colson P., Raoult D. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int. J. Antimicrob. Agents 2007, 30:297-308.
45. Murray S.M., Down C.M., Boulware D.R., Stauffer W.M., Cavert W.P., Schacker T.W., Brenchley J.M., Douek D.C. Reduction of immune activation with chloroquine therapy during chronic HIV infection. J. Virol. 2010, 84:12082-12086.
46. Romanelli F., Smith K.M., Hoven A.D. Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity. Curr. Pharm. Des. 2004, 10:2643-2648.
47. Aguirre-Cruz L., Torres K.J., Jung-Cook H., Fortuny C., Sánchez E., Soda-Mehry A., Sotelo J., Reyes-Terán G. Short communication: preferential concentration of hydroxychloroquine in adenoid tissue of HIV-infected subjects. AIDS Res. Hum. Retroviruses 2010, 26:339-342.